SCHEMBL11339249

SCHEMBL11339249

Cc1cc(C(=O)Nc2cccc3c(O)c(S(=O)(=O)O)ccc23)ccc1NC(=O)Nc1ccc(C(=O)Nc2cccc3c(O)c(S(=O)(=O)O)ccc23)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 4/20 0.48
TIMP3 P35625 4/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
RECQL P46063 3/20 0.48
HSD17B10 Q99714 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
USP2 O75604 2/20 0.48
P2RY11 Q96G91 2/20 0.48
MAPT P10636 2/20 0.48
PKM P14618 2/20 0.48
BRCA1 P38398 2/20 0.48
SIRT2 Q8IXJ6 2/20 0.48
SIRT1 Q96EB6 2/20 0.48
ENPP3 O14638 1/20 0.48
ENTPD3 O75355 1/20 0.48
NR1I2 O75469 1/20 0.48
PRKD3 O94806 1/20 0.48
TDP2 O95551 1/20 0.48
CBX7 O95931 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907794 0.94 HPSE (0.44) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11347629 0.89 HPSE (0.46) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11344939 0.88 HPSE (0.49) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11427941 0.87 MEN1 (0.41) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11343444 0.86 HPSE (0.52) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11419261 0.85 HPSE (0.46) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11433623 0.85 MEN1 (0.43) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11340795 0.84 HPSE (0.48) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11348250 0.84 HPSE (0.46) HPSETIMP3MEN1KMT2ARECQL
SCHEMBL11346504 0.84 RECQL (0.54) HPSETIMP3MEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed